Treatment resistance in tourette syndrome

2Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Tourette syndrome (TS) is a complex neurodevelopmental disorder characterized by the presence of multiple motor and phonic tics that begin during childhood and persist for more than 1 year. TS is frequently associated with psychopathology, and its treatment is particularly challenging, as the genetics, neurophysiology, and neuropathology of the disorder remain largely unknown. Moreover, there are currently no guidelines for the treatment of refractory TS. In this chapter, we review routine strategies for the management of refractory TS, as well as the therapeutic potential of novel pharmacological approaches, deep brain stimulation (DBS), and repetitive transcranial magnetic stimulation (rTMS).

Cite

CITATION STYLE

APA

Rizzo, R., & Gulisano, M. (2018). Treatment resistance in tourette syndrome. In Treatment Resistance in Psychiatry: Risk Factors, Biology, and Management (pp. 237–252). Springer Singapore. https://doi.org/10.1007/978-981-10-4358-1_16

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free